Suchergebnisse - "Spinner, Christoph D"

PubPharm (10)

1

Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir : a DUALIS sub-study

enthalten in: AIDS care | 2022

von Olliges, E. | Bührlen, B. | Fischer, F. | +14

2

Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

enthalten in: HIV research & clinical practice | 2021

von Monin, M. | Kümmerle, T. | Schneider, J. | +16

3

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

enthalten in: AIDS research and therapy | 2021

von Wolf, E. | Boesecke, C. | Balogh, A. | +9

4

Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1

enthalten in: HIV research & clinical practice | 2020

von Huhn, G. | Wilkin, A. | Mussini, C. | +8

5

COVID-19 in people living with human immunodeficiency virus : a case series of 33 patients

enthalten in: Infection | 2020

von Härter, G. | Spinner, C. | Roider, J. | +11

6

Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir : a pharmacokinetic subgroup analysis of the DUALIS study

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Weidlich, S. | Boesecke, C. | Schneider, J. | +36

7

Are 96-week data enough for doravirine to DRIVE FORWARD?

enthalten in: The lancet. HIV | 2020

von Spinner, C. | Barber, T.

CommentOn: Lancet HIV. 2020 Jan;7(1):e16-e26. - PMID 31740348

8

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1 : subgroup analyses of the phase 3 AMBER study

enthalten in: HIV research & clinical practice | 2019

von Rashbaum, B. | Spinner, C. | McDonald, C. | +6

9

Pharmacokinetics of once-daily dolutegravir and ritonavir-boosted darunavir in HIV patients : the DUALIS study

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Spinner, C. | Kümmerle, T. | Krznaric, I. | +6

10

Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers : results from the STRIBILD-IR study

enthalten in: Antiviral therapy | 2016

von Spinner, C. | Kern, K. | Zink, A. | +7

1
[1]